Risk of Urinary Retention With Retigabine

NCT01462656 · clinicaltrials.gov ↗
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped This study was halted as the preliminary analysis revealed that the numbers were too low to warrant continuing the project

Conditions

Interventions

Sponsor

GlaxoSmithKline